SUO Annual Meeting

Articles

In this interview, Curtis A. Pettaway, MD, reflects on what innovations and research led to his becoming the first Black recipient of the Society of Urologic Oncology’s Huggins Award.

First Black recipient of prestigious SUO award discusses his path in urology

"I was very early among the first women in urology, and in those days it was really going out on a limb to go into that field," said Eila C. Skinner, MD.

Renowned urologist Dr. Eila Skinner reflects on her journey in the field

Videos

“Imaging advances with PSMA-directed modalities…are absolutely shifting the landscape,” says Alicia K. Morgans, MD, MPH.

Dr. Morgans highlights research and advancements from SUO 2021

“We…had 1 of the largest African American hereditary prostate cancer projects funded through the National Cancer Institute,” says Curtis A. Pettaway, MD.

Dr. Curtis Pettaway’s achievements and contributions in the field of urology

“We’re [going to] have a whole new era of immune therapies and different novel ways to treat [patients], and then [utilize] combinations of these therapies,” says Michael S. Cookson, MD, MMHC, FACS.

Dr. Cookson on current and future advancement in GU cancer care

“If you're thinking about urology, then what I would do is get exposure as early as possible,” says Curtis A. Pettaway, MD.

Advice for students looking to pursue urology from the 2021 Huggins Medal recipient

“As president of SUO, it's really rewarding to be able to hand these giants these great awards,” says Michael S. Cookson, MD, MMHC, FACS.

Dr. Cookson applauds this year’s SUO award recipients

“I believe that this is, of course,…a harbinger of what is to come—those of underserved backgrounds being…featured [more] in our organizations,” says Curtis A. Pettaway, MD.

Dr. Pettaway: 2021 recipient of SUO’s Huggins Medal

“The SUO has never been stronger in its ability to deliver on clinical trials,” says Michael S. Cookson, MD, MMHC, FACS.

Research highlights from the 2021 SUO Annual Meeting

"Although, as urologic oncologists, we all see a few cases in our practices individually, I think, no question, there's a lot of heterogeneity in how penile cancer is managed across the United States," says Philippe E. Spiess, MD, MS.